hnRNPA2B1 and CD138 (myeloma cells surface marker) expression were higher in myeloma cells from patient with high bone lesion numbers (P1) than in those from patient with low lesion numbers (P2) (Figure 1J). Here, HNRNPA2B1 is linked to plasma cell myeloma.